To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 6, 2023)
This bill broadens the authority of pharmacies under the Controlled Substances Act to deliver certain controlled substances to health care practitioners for the purpose of administering the substance to a patient.
Under current law, pharmacies may deliver controlled substances in schedules III, IV, or V to a practitioner if it is for maintenance or detoxification treatment and is administered via injection or implantation, among other requirements. The bill applies this authority to any controlled substance in schedules III, IV, or V that is approved by the Food and Drug Administration to be administered by, or under the supervision of, a practitioner.
What just happenedJul 7, 2023
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 6, 2023
- Jul 7, 2023Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 6, 2023IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Jul 6, 2023IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 6, 2023IntroReferralIntro-H
Introduced in House
- Jul 6, 2023IntroReferral1000
Introduced in House